AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-7.19%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$1.56B
AUM Growth
+$1.56B
(-16%)
Cap. Flow
-$88.9M
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
82.51%
Holding
49
New
2
Increased
–
Reduced
3
Closed
4
Top Buys
| 1 |
Arm
ARM
|
$105M |
| 2 |
Neumora Therapeutics
NMRA
|
$2.82M |
Top Sells
| 1 |
Oscar Health
OSCR
|
$53.3M |
| 2 |
DexCom
DXCM
|
$52.1M |
| 3 |
Dianthus Therapeutics
DNTH
|
$42.8M |
| 4 |
Lyft
LYFT
|
$35.5M |
| 5 |
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
|
$6.3M |
Sector Composition
| 1 | Technology | 54.11% |
| 2 | Healthcare | 39.18% |
| 3 | Industrials | 6.37% |
| 4 | Consumer Staples | 0.33% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$5.95B
| $241M | 15.46% | 14,068,674 | – | – |
|
2
CrowdStrike
CRWD
$106B
| $215M | 13.8% | 1,283,683 | – | – |
|
|
VERV
3
DELISTED
Verve Therapeutics
VERV
| $140M | 8.98% | 10,549,086 | – | – |
|
4
GitLab
GTLB
$7.93B
| $120M | 7.69% | 2,647,312 | – | – |
|
5
Prime Medicine
PRME
$578M
| $113M | 7.27% | 11,862,498 | – | – |
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $106M | 6.8% | 47,675,476 | – | – |
|
|
7
Arm
ARM
$147B
| $105M | 6.74% | +1,960,784 | New | +$105M |
|
8
Planet Labs
PL
$2.15B
| $83.1M | 5.33% | 31,942,641 | – | – |
|
9
Snowflake
SNOW
$79.6B
| $81.8M | 5.26% | 535,604 | – | – |
|
|
10
Oscar Health
OSCR
$4.31B
| $80.6M | 5.18% | 14,477,374 -9,565,490 | -40% | -$53.3M |
|
11
Freshworks
FRSH
$3.93B
| $80.4M | 5.16% | 4,035,595 | – | – |
|
|
12
DexCom
DXCM
$29.5B
| $61.1M | 3.92% | 654,854 -557,952 | -46% | -$52.1M |
|
|
DM
13
DELISTED
Desktop Metal, Inc.
DM
| $16.1M | 1.04% | 11,048,730 | – | – |
|
14
Relay Therapeutics
RLAY
$619M
| $13.2M | 0.85% | 1,568,753 | – | – |
|
15
Sana Biotechnology
SANA
$777M
| $10.9M | 0.7% | 2,812,500 | – | – |
|
16
Invivyd
IVVD
$204M
| $9.66M | 0.62% | 5,680,785 | – | – |
|
17
RAPT Therapeutics
RAPT
$188M
| $8.98M | 0.58% | 540,270 | – | – |
|
18
Lyell Immunopharma
LYEL
$213M
| $8.62M | 0.55% | 5,865,125 | – | – |
|
19
Beam Therapeutics
BEAM
$1.66B
| $7.73M | 0.5% | 321,604 | – | – |
|
20
Illumina
ILMN
$15.8B
| $7.34M | 0.47% | 53,470 | – | – |
|
21
Monte Rosa Therapeutics
GLUE
$296M
| $7.01M | 0.45% | 1,464,015 | – | – |
|
|
BHIL
22
DELISTED
Benson Hill, Inc.
BHIL
| $5.07M | 0.33% | 15,352,271 | – | – |
|
|
BRNS
23
Barinthus Biotherapeutics
BRNS
$45.6M
| $4.68M | 0.3% | 1,513,644 | – | – |
|
24
Vera Therapeutics
VERA
$1.38B
| $4.13M | 0.27% | 301,580 | – | – |
|
|
25
Dianthus Therapeutics
DNTH
$759M
| $2.85M | 0.18% | 208,697 -3,130,441 | -94% | -$42.8M |
|